An Overview on Pharmaceutical Supply Chain: A
Next Step towards Good Manufacturing Practice
Volume 1 - Issue 2
Kapoor D1*, Vyas RB1 and Dadarwal D2
-
Author Information
Open or Close
- 1Dr. Dayaram Patel Pharmacy College, India
- 2Sanjeevni College of Pharmaceutical Sciences, India
*Corresponding author:
Devesh Kapoor, Dr. Dayaram Patel Pharmacy College, Sardar baug, Station Road, Bardoli, Surat,
Gujarat, India
Received: March 23, 2018; Published: March 29, 2018
DOI: 10.32474/DDIPIJ.2018.01.000107
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
The top priority in any health system is delivering of medicine as a strategic product. In the present context of a health-conscious
society, management of pharmaceutical supply chains has become more complex because it involves the life-saving interest of human
being and requires the participation of different stakeholders such as pharmaceutical manufacturers, wholesalers, distributors,
customers, information service providers and regulatory agencies. Limited research is available in the area of pharmaceutical
supply chains. Pharmaceutical companies, a most important player of the drug supply chain, are subject to many risks. These risks
interrupt the quantity and quality of supply of medicine and their delivery to the accurate place and customers and at the correct
time.
Keywords: Drug Counterfeiting; Temperature Controlled Logistics; Supplier Qualification; Performance Management;
Globalization; Sustainability
Abbrevations: OTC: Over the Counter; CDSCO: Central Drug Standards and Control Organization; NPPA: National Pharmaceutical
Pricing Authority; RFID:Radio Frequency Identification Technology; EPC: Electronic Product Code; EPC: Electronic Product Code
Abstract|
Introduction|
Benefits of Supply Chain Management|
Drug Counterfeiting|
Standard Operating Procedure for Supplier
Qualification (SOP)|
Conclusion|
References|